The missense mutation EGFR L858R in exon 21, which accounts for 41% of all EGFR mutations, has been detected in lung cancer, colorectal cancer, and squamous cell carcinoma of the head and neck (Shigematsu and Gazdar, 2006). The gene discussed is EGFR; the disease is lung carcinoma.